Trial intelligence / Profile preview

Mini-Dose Glucagon for Ramadan Fasting Hypoglycemia

NCT03970772Completed

Sponsor
Qassim University
Start
Apr 2019
Primary completion
Jun 2019
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of glucagon in hypoglycemia (2 arms), sponsored by Qassim University. Primary endpoints: Changes in glucose values from baseline to 30 minute and Number of treated fasting induced hypoglycemic events at 2 weeks. Started Apr 2019; status: completed.

02

Drugs

glucagon
03

Conditions

hypoglycemia

Beyond the preview

Go deeper on NCT03970772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03970772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call